Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines

ABSTRACT: Introduction and aim. Epigenetic alterations pl Introduction and aim. ay an essential role in cancer onset and progression, thus studies of drugs targeting the epigenetic machinery are a principal concern for cancer treatment. Here, we evaluated the potential of the DNA methyltransferase i...

Full description

Autores:
Uribe Yunda, Diego Fernando
Cardona Echeverry, Andrés Hernán
Esposti, Davide Degli
Cros, Marie Pierre
Cuenin, Cyrille
Herceg, Zdenko
Camargo Guerrero, Mauricio
Cortés Mancera, ‪Fabian Mauricio
Tipo de recurso:
Article of investigation
Fecha de publicación:
2018
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/20090
Acceso en línea:
http://hdl.handle.net/10495/20090
https://www.sciencedirect.com/science/article/pii/S1665268119302005?via%3Dihub
Palabra clave:
Liver Neoplasms
Neoplasias Hepáticas
DNA Methylation
Metilación de ADN
Cadherins
Cadherinas
Wnt Signaling Pathway
Vía de Señalización Wnt
TSA
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_7e245c70ed64d38823d56732ed13f4d2
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/20090
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
title Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
spellingShingle Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
Liver Neoplasms
Neoplasias Hepáticas
DNA Methylation
Metilación de ADN
Cadherins
Cadherinas
Wnt Signaling Pathway
Vía de Señalización Wnt
TSA
title_short Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
title_full Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
title_fullStr Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
title_full_unstemmed Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
title_sort Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines
dc.creator.fl_str_mv Uribe Yunda, Diego Fernando
Cardona Echeverry, Andrés Hernán
Esposti, Davide Degli
Cros, Marie Pierre
Cuenin, Cyrille
Herceg, Zdenko
Camargo Guerrero, Mauricio
Cortés Mancera, ‪Fabian Mauricio
dc.contributor.author.none.fl_str_mv Uribe Yunda, Diego Fernando
Cardona Echeverry, Andrés Hernán
Esposti, Davide Degli
Cros, Marie Pierre
Cuenin, Cyrille
Herceg, Zdenko
Camargo Guerrero, Mauricio
Cortés Mancera, ‪Fabian Mauricio
dc.subject.decs.none.fl_str_mv Liver Neoplasms
Neoplasias Hepáticas
DNA Methylation
Metilación de ADN
Cadherins
Cadherinas
Wnt Signaling Pathway
Vía de Señalización Wnt
topic Liver Neoplasms
Neoplasias Hepáticas
DNA Methylation
Metilación de ADN
Cadherins
Cadherinas
Wnt Signaling Pathway
Vía de Señalización Wnt
TSA
dc.subject.proposal.spa.fl_str_mv TSA
description ABSTRACT: Introduction and aim. Epigenetic alterations pl Introduction and aim. ay an essential role in cancer onset and progression, thus studies of drugs targeting the epigenetic machinery are a principal concern for cancer treatment. Here, we evaluated the potential of the DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine (5aza-dC) and the pan-deacetylase inhibitor Trichostatin A (TSA), at low cytotoxic concentrations, to modulate the canonical Wnt/E-catenin pathway in liver cancer cells. Material and Material and methods. methods. Pyrosequencing was used for DNA methylation analyses of LINE-1 sequences and the Wnt/E-catenin pathway antagonist DKK3, SFRP1, WIF1 and CDH1. qRT-PCR was employed to verify the expression of the antagonist. Pathway regulation were evaluated looking at the expression of E-catenin and E-cadherin by confocal microscopy and the antitumoral effects of the drugs was studied by wound healing and clonogenic assays. Results. Our resul Results. t suggest that 5aza-dC and TSA treatments were enough to induce a significant expression of the pathway antagonists, decrease of E-catenin protein levels, re-localization of the protein to the plasma membrane, and pathway transcriptional activity reduction. These important effects exerted an antitumoral outcome shown by the reduction of the migration and clonogenic capabilities of the cells. Conclusion. We were able to demonstrate Wnt/ Conclusion. E-catenin pathway modulation through E-cadherin up-regulation induced by 5aza-dC and TSA treatments, under an activation-pathway background, like CTNNB1 and TP53 mutations. These findings provide evidences of the potential effect of epigenetic modifier drugs for liver cancer treatment. However, further research needs to be conducted, to determine the in vivo potential of this treatment regimen for the management of liver cancer.
publishDate 2018
dc.date.issued.none.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2021-06-11T03:25:35Z
dc.date.available.none.fl_str_mv 2021-06-11T03:25:35Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1665-2681
10.5604/01.3001.0011.7389
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/20090
dc.identifier.url.spa.fl_str_mv https://www.sciencedirect.com/science/article/pii/S1665268119302005?via%3Dihub
identifier_str_mv 1665-2681
10.5604/01.3001.0011.7389
url http://hdl.handle.net/10495/20090
https://www.sciencedirect.com/science/article/pii/S1665268119302005?via%3Dihub
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Ann. hepatol.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 17
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Ediciones Medicina y Cultura
dc.publisher.group.spa.fl_str_mv Genética Regeneración y Cáncer
dc.publisher.place.spa.fl_str_mv México
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/20090/1/UribeDiego_2018_EpigenticLiverCancer.pdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/20090/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/20090/3/license.txt
bitstream.checksum.fl_str_mv c0e548c96975f3b6152ccc8a3fb94412
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173092152147968
spelling Uribe Yunda, Diego FernandoCardona Echeverry, Andrés HernánEsposti, Davide DegliCros, Marie PierreCuenin, CyrilleHerceg, ZdenkoCamargo Guerrero, MauricioCortés Mancera, ‪Fabian Mauricio2021-06-11T03:25:35Z2021-06-11T03:25:35Z20181665-268110.5604/01.3001.0011.7389http://hdl.handle.net/10495/20090https://www.sciencedirect.com/science/article/pii/S1665268119302005?via%3DihubABSTRACT: Introduction and aim. Epigenetic alterations pl Introduction and aim. ay an essential role in cancer onset and progression, thus studies of drugs targeting the epigenetic machinery are a principal concern for cancer treatment. Here, we evaluated the potential of the DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine (5aza-dC) and the pan-deacetylase inhibitor Trichostatin A (TSA), at low cytotoxic concentrations, to modulate the canonical Wnt/E-catenin pathway in liver cancer cells. Material and Material and methods. methods. Pyrosequencing was used for DNA methylation analyses of LINE-1 sequences and the Wnt/E-catenin pathway antagonist DKK3, SFRP1, WIF1 and CDH1. qRT-PCR was employed to verify the expression of the antagonist. Pathway regulation were evaluated looking at the expression of E-catenin and E-cadherin by confocal microscopy and the antitumoral effects of the drugs was studied by wound healing and clonogenic assays. Results. Our resul Results. t suggest that 5aza-dC and TSA treatments were enough to induce a significant expression of the pathway antagonists, decrease of E-catenin protein levels, re-localization of the protein to the plasma membrane, and pathway transcriptional activity reduction. These important effects exerted an antitumoral outcome shown by the reduction of the migration and clonogenic capabilities of the cells. Conclusion. We were able to demonstrate Wnt/ Conclusion. E-catenin pathway modulation through E-cadherin up-regulation induced by 5aza-dC and TSA treatments, under an activation-pathway background, like CTNNB1 and TP53 mutations. These findings provide evidences of the potential effect of epigenetic modifier drugs for liver cancer treatment. However, further research needs to be conducted, to determine the in vivo potential of this treatment regimen for the management of liver cancer.COL000676917application/pdfengEdiciones Medicina y CulturaGenética Regeneración y CáncerMéxicoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell LinesLiver NeoplasmsNeoplasias HepáticasDNA MethylationMetilación de ADNCadherinsCadherinasWnt Signaling PathwayVía de Señalización WntTSAAnn. hepatol.Annals of Hepatology444460173ORIGINALUribeDiego_2018_EpigenticLiverCancer.pdfUribeDiego_2018_EpigenticLiverCancer.pdfArtículo de investigaciónapplication/pdf1347235http://bibliotecadigital.udea.edu.co/bitstream/10495/20090/1/UribeDiego_2018_EpigenticLiverCancer.pdfc0e548c96975f3b6152ccc8a3fb94412MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/20090/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/20090/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/20090oai:bibliotecadigital.udea.edu.co:10495/200902021-06-10 22:25:36.112Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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